PT2399, an HIF-2α-specific antagonist, has been shown to protect mice from diet-induced obesity by decreasing body weight, adipogenesis and lipogenesis when administered for 8 weeks23. The gene discussed is EPAS1; the disease is obesity due to melanocortin 4 receptor deficiency.